Akshaya Keerti/LinkedIn
Sep 22, 2024, 02:10
Akshaya Keerti: The potential of Datopotamab Deruxtecan in lung cancer
Akshaya Keerti shared a post on LinkedIn:
”Excited to share my latest blog on the groundbreaking potential of Datopotamab Deruxtecan in transforming lung cancer treatment! Discover how this innovative drug is making strides in improving survival rates for NSCLC patients.”
Read further.
Source: Akshaya Keerti/LinkedIn
Akshaya Keerti is the International Council Deputy Director at the Federation of Medical Students Association (FMSA) and a Professional Member of Erevnites. He also serves as a Medical Officer at Meherbai Tata Memorial Cancer Hospital and is an Academic Lecturer with Project IMG.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 2, 2025, 12:03
Sep 2, 2025, 11:41
Sep 2, 2025, 11:39
Sep 2, 2025, 11:33
Sep 2, 2025, 11:24
Sep 2, 2025, 11:15